Type 1 and type 2 iodothyronine deiodinases in the thyroid gland of patients with 3,5,3′-triiodothyronine-predominant Graves' disease

European Journal of Endocrinology

Volumn 164, Issue 1, 2011, Pages 95-100

  Ito, Mitsuru ^a   Toyoda, Nagaoki ^b   Nomura, Emiko ^b   Takamura, Yuuki ^a   Amino, Nobuyuki ^a   Iwasaka, Toshiji ^b   Takamatsu, Junta ^c   Miyauchi, Akira ^a   Nishikawa, Mitsushige ^b  

^a KUMA HOSPITAL   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c Takamatsu Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IODOTHYRONINE DEIODINASE TYPE 1; IODOTHYRONINE DEIODINASE TYPE 2; LIOTHYRONINE; MESSENGER RNA; PEROXIDASE; THIAMAZOLE; THYROXINE; UNCLASSIFIED DRUG; THYROXINE DEIODINASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GRAVES DISEASE; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; THYROID GLAND; THYROIDECTOMY; CORRELATION ANALYSIS; LIOTHYRONINE BLOOD LEVEL; RNA ANALYSIS; THYROXINE BLOOD LEVEL; TISSUE LEVEL;

ADULT; AGED; ANTITHYROID AGENTS; BIOLOGICAL MARKERS; FEMALE; GRAVES DISEASE; HUMANS; IODIDE PEROXIDASE; MALE; METHIMAZOLE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID GLAND; THYROIDECTOMY; THYROXINE; TRIIODOTHYRONINE;

EID: 78751513622     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0736     Document Type: Article

References (26)

1. Larsen PR, Silva JE & Kaplan MM. Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocrine Reviews 1981 2 87-102. (doi:10.1210/edrv-2-1-87)
2. St Germain DL & Galton VA. The deiodinase family of selenoproteins. Thyroid 1997 7 655-668. (doi:10.1089/thy.1997.7.655)
3. Bianco AC, Salvatore D, Gereben B, Berry MJ & Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocrine Reviews 2002 23 38-89. (doi:10.1210/er.23.1.38) (Pubitemid 34185306)
4. Kuiper GGJM, Kester MHA, Peeters RP & Visser TJ. Biochemical mechanisms of thyroid hormone deiodination. Thyroid 2005 15 787-798. (doi:10.1089/thy.2005.15.787)
5. Salvatore D, Tu H, Harney JW & Larsen PR. Type 2 iodothyronine deiodinase is highly expressed in human thyroid. Journal of Clinical Investigation 1996 98 962-968. (doi:10.1172/JCI118880)
6. Laurberg P, Vestergaard H, Nielsen S, Christensen SE, Seefeldt T, Helleberg K & Pedersen KM. Source of circulating 3,5,3′- triiodothyronine in hyperthyroidism estimated after blocking type 1 and type 2 iodothyronine deiodinses. Journal of Clinical Endocrinology and Metabolism 2007 92 2149-2156. (doi:10.1210/jc.2007-0178)
7. Kim BW, Daniels GH, Harrison BJ, Price A, Harney JW, Larsen PR & Weetman AP. Overexpression of type 2 iodothyronine deiodinase in follicular carcinoma as a cause of low circulating free thyroxine levels. Journal of Clinical Endocrinology and Metabolism 2003 88 594-598. (doi:10.1210/jc.2002- 020921)
8. Weetman AP, Shepherdley CA, Mansell P, Ubhi CS & Visser TJ. Thyroid over-expression of type 1 and type 2 deiodinase may account for the syndrome of low thyroxine and increasing triiodothyronine during propylthiouracil treatment. European Journal of Endocrinology 2003 149 443-447. (doi:10.1530/eje.0.1490443) (Pubitemid 37461527)
9. Kanou Y, Hishinuma A, Tsunekawa K, Seki K, Mizuno Y, Fujisawa H, Imai T, Miura Y, Nagasaka T, Yamada C, Ieiri T, Murakami M & Murata Y. Thyroglobulin gene mutations producing defective intracellular transport of thyroglobulin are associated with increased type 2 iodothyronine deiodinase activity. Journal of Clinical Endocrinology and Metabolism 2007 92 1451-1457. (doi:10.1210/jc.2006- 1242)
10. Celi FS, Coppotelli G, Chidakel A, Kelly M, Brillante BA, Shawker T, Cherman N, Feuillan PP & Collins MT. The role of type 1 and type 2 5′-deiodinase in the pathophysiology of the 3,5,3′-triiodothyronine toxicosis of McCune-Albright syndrome. Journal of Clinical Endocrinology and Metabolism 2008 93 2383-2389. (doi:10.1210/jc.2007-2237)
11. Takamatsu J, Sugawara M, Kuma K, Kobayashi A, Matsuzuka F, Mozai T & Hershman JM. Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease. Annals of Internal Medicine 1984 100 372-375.
12. Hegedüs L, Hansen JM, Bech K, Kampmann JP, Jensen K, Andersen E, Hansen P, Karstrup S & Bliddal H. Thyroid stimulating immunoglobulins in Graves' disease with goiter growth, low thyroxine and increasing triiodothyronine during PTU treatment. Acta Endocrinologica 1984 107 482-488. (doi:10.1530/acta.0.1070482) (Pubitemid 15216160)
13. Chan JJS & Ladenson PW. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease. Journal of Clinical Endocrinology and Metabolism 1986 63 102-106. (doi:10.1210/jcem-63-1-102)
14. Costagliola S, Morgenthaler NG, Hoermann R, Badenhoop K, Struck J, Freitag D, Poertl S, Weglöhner W, Hollidt JM, Quadbeck B, Dumont JE, Schumm-Draeger PM, Bergmann A, Mann K, Vassart G & Usadel KH. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. Journal of Clinical Endocrinology and Metabolism 1999 84 90-97. (doi:10.1210/jc.84.1.90)
15. Inui T, Kouki T, Yamashiro K, Hachiya T, Ochi Y, Kajita Y, Sato Y & Nagata A. Increase of thyroid stimulating activity in Graves' immunoglobulin-G by high polyethylene glycol concentrations using porcine thyroid cell assay. Thyroid 1998 8 319-325. (doi:10.1089/thy.1998.8.319)
16. Murakami Y, Takamatsu J, Sakane S, Kuma K & Ohsawa N. Changes in thyroid volume in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome. Journal of Clinical Endocrinology and Metabolism 1996 81 3257-3260. (doi:10.1210/jc.81.9.3257)
17. Bellabarba D, Peterson RE & Sterling K. An improved method for chromatography of iodothyronines. Journal of Clinical Endocrinology and Metabolism 1968 28 305-307. (doi:10.1210/jcem-28-2-305)
18. Laurberg P. Thyroxine entering the thyroid gland via the vascular bed may leave the gland as triiodothyronines. Studies with perfused dog thyroid lobes. Endocrinology 1986 118 895-900. (doi:10.1210/endo-118-3-895)
19. Toyoda N, Zavacki AM, Maia AL, Harney JW & Larsen PR. A novel retinoid X receptor-independent thyroid hormone response element is present in the human type 1 deiodinase gene. Molecular and Cellular Biology 1995 15 5100-5112.
20. Gereben B, Goncalves C, Harney JW, Larsen PR & Bianco AC. Selective proteolysis of human type 2 deiodinase: a novel ubiquitin-proteasomal mediated mechanism for regulation of hormone activation. Molecular Endocrinology 2000 14 1697-1708. (doi:10.1210/me.14.11.1697)
21. 3 in euthyroid humans. Journal of Clinical Investigation 2005 115 2524-2533. (doi:10.1172/JCI25083)
22. Bartha T, Kim SW, Salvatore D, Gereben B, Tu HM, Harney JW, Rudas P & Larsen PR. Characterization of the 5′-flanking and 5′-untranslated regions of the cyclic adenosine 3′,5′-monophosphate-responsive human type 2 iodothyronine deiodinase gene. Endocrinology 2003 140 229-237. (doi:10.1210/en.141.1.229)
23. Canettieri G, Celi FS, Baccheschi G, Salvatori L, Andreoli M & Centanni M. Isolation of human type 2 deiodinase gene promoter and characterization of a functional cyclic adenosine monophosphate response element. Endocrinology 2000 141 1804-1813. (doi:10.1210/en.141.5.1804) (Pubitemid 32274411)
24. Burmeister LA, Pachucki J & St Germain DL. Thyroid hormones inhibit type 2 iodothyronine deiodinase in the rat cerebral cortex by both pre- and posttranslational mechanisms. Endocrinology 1997 138 5231-5237. (doi:10.1210/en.138.12.5231) (Pubitemid 27509683)
25. Kim SW, Harney JW & Larsen PR. Studies of the hormonal regulation of type 2 5′-iodothyronine deiodinase messenger ribonucleic acid in pituitary tumor cells using semiquantitative reverse transcription-polymerase chain reaction. Endocrinology 1998 139 4895-4905. (doi:10.1210/en.139.12.4895)
26. Takamatsu J, Hosoya T, Naito N, Yoshimura H, Kohno Y, Tarutani O, Kuma K, Sakane S, Takeda K & Mozai T. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease. Journal of Clinical Endocrinology and Metabolism 1988 66 147-152. (doi:10.1210/jcem-66-1-147)